Tenax Therapeutics Stock Shares Outstanding
| TENX Stock | USD 3.56 0.06 1.71% |
Tenax Therapeutics fundamentals help investors to digest information that contributes to Tenax Therapeutics' financial success or failures. It also enables traders to predict the movement of Tenax Stock. The fundamental analysis module provides a way to measure Tenax Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tenax Therapeutics stock.
Common Stock Shares Outstanding is likely to rise to about 260.9 K in 2024. Tenax | Shares Outstanding |
Tenax Therapeutics Company Shares Outstanding Analysis
Tenax Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Tenax Therapeutics Shares Outstanding | 1.96 M |
Most of Tenax Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tenax Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Tenax Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Tenax Therapeutics is extremely important. It helps to project a fair market value of Tenax Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Tenax Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Tenax Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Tenax Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Tenax Shares Outstanding Historical Pattern
Today, most investors in Tenax Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tenax Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Tenax Therapeutics shares outstanding as a starting point in their analysis.
Tenax Therapeutics Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Tenax Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Tenax Therapeutics has 1.96 M of shares currently outstending. This is 98.92% lower than that of the Biotechnology sector and 98.17% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.66% higher than that of the company.
Tenax Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tenax Therapeutics' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tenax Therapeutics could also be used in its relative valuation, which is a method of valuing Tenax Therapeutics by comparing valuation metrics of similar companies.Tenax Therapeutics is currently under evaluation in shares outstanding category among related companies.
Tenax Fundamentals
| Return On Equity | -1.61 | ||||
| Return On Asset | -0.68 | ||||
| Current Valuation | (2.44 M) | ||||
| Shares Outstanding | 1.96 M | ||||
| Shares Owned By Insiders | 0.35 % | ||||
| Shares Owned By Institutions | 4.07 % | ||||
| Number Of Shares Shorted | 48.99 K | ||||
| Price To Earning | (0.35) X | ||||
| Price To Book | 0.91 X | ||||
| EBITDA | (8.23 M) | ||||
| Net Income | (7.71 M) | ||||
| Cash And Equivalents | 7.23 M | ||||
| Cash Per Share | 0.29 X | ||||
| Total Debt | 500.9 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 5.60 X | ||||
| Book Value Per Share | 27.15 X | ||||
| Cash Flow From Operations | (5.9 M) | ||||
| Short Ratio | 0.32 X | ||||
| Earnings Per Share | (31.04) X | ||||
| Target Price | 32.5 | ||||
| Beta | 2.27 | ||||
| Market Capitalization | 6.85 M | ||||
| Total Asset | 11.68 M | ||||
| Retained Earnings | (297.25 M) | ||||
| Working Capital | 8.1 M | ||||
| Current Asset | 21.86 M | ||||
| Current Liabilities | 3.56 M | ||||
| Net Asset | 11.68 M |
About Tenax Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tenax Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tenax Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tenax Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tenax Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tenax Therapeutics' short interest history, or implied volatility extrapolated from Tenax Therapeutics options trading.
Currently Active Assets on Macroaxis
When determining whether Tenax Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenax Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenax Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenax Therapeutics Stock:Check out Tenax Therapeutics Piotroski F Score and Tenax Therapeutics Altman Z Score analysis. For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Tenax Stock analysis
When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Tenax Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenax Therapeutics. If investors know Tenax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenax Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (31.04) | Return On Assets (0.68) | Return On Equity (1.61) |
The market value of Tenax Therapeutics is measured differently than its book value, which is the value of Tenax that is recorded on the company's balance sheet. Investors also form their own opinion of Tenax Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tenax Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenax Therapeutics' market value can be influenced by many factors that don't directly affect Tenax Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenax Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenax Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenax Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.